Advanced search
Publication Cover
Acta Cardiologica Volume 76, 2021 - Issue 2
Submit an article Journal homepage
445
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

COVID-19 epidemic: anticoagulants treatments, another victim

Frédéric LapostolleSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, FranceCorrespondence[email protected]
,
Isabelle VianuSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France
,
Tomislav PetrovicSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France
&
Frédéric AdnetSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France
Pages 222-223 | Received 18 Jul 2020, Accepted 11 Aug 2020, Published online: 14 Dec 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"COVID-19 epidemic: anticoagulants treatments, another victim." Acta Cardiologica, 76(2), pp. 222–223

Disclosure statement

FL: Astra-Zeneca, Bayer, BMS, Boehringer-Ingelheim, Lilly, Medtronic, Merck-Serono, Mundipharma, Novartis, Pfizer, Serb, Teleflex and The Medicine Company, IV, TP, FA: none.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.